Stay updated with breaking news from Nasdaq Amph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) CFO William J. Peters sold 5,632 shares of Amphastar Pharmaceuticals stock in a transaction that occurred on Monday, April 17th. The stock was sold at an average price of $42.35, for a total transaction of $238,515.20. Following the transaction, the chief financial officer now directly owns 105,148 shares […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) reached a new 52-week high during trading on Monday . The stock traded as high as $42.35 and last traded at $41.72, with a volume of 41301 shares changing hands. The stock had previously closed at $42.15. Analyst Upgrades and Downgrades Separately, StockNews.com upgraded Amphastar Pharmaceuticals from a […]
Anfield Capital Management LLC raised its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 67.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,027 shares of the company’s stock after buying an additional 413 shares during the quarter. Anfield […]
Anfield Capital Management LLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) by 67.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,027 shares of the company’s stock after acquiring an additional 413 shares during the quarter. Anfield Capital Management LLC’s holdings in Amphastar Pharmaceuticals were worth $29,000 […]
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Get Rating) EVP Yakob Liawatidewi sold 5,000 shares of the stock in a transaction on Monday, April 10th. The shares were sold at an average price of $40.00, for a total transaction of $200,000.00. Following the transaction, the executive vice president now directly owns 69,215 shares in the company, valued […]